Pulmonary Hypertension News Forums › Forums › Research and Development › TLR3 Immune Receptor Seen As a Promising Therapeutic Target in Rat Study

  • Research & Development

    TLR3 Immune Receptor Seen As a Promising Therapeutic Target in Rat Study

    Posted by Pulmonary Hypertension News Moderator on September 19, 2018 at 5:43 pm

    Stimulating the activity of an immune system receptor called TLR3 reduced pulmonary hypertension symptoms in a rodent study of the disease.

    The study, “Toll-like Receptor 3 is a Therapeutic Target for Pulmonary Hypertension,” was published in the journal American Journal of Respiratory and Critical Care Medicine. Read a summary of it here.

    What are your thoughts on this news?

    replied 5 years, 7 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .